State Board of Administration of Florida Retirement System Has $22.23 Million Position in Henry Schein, Inc. (HSIC)

State Board of Administration of Florida Retirement System raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,478 shares of the company’s stock after buying an additional 557 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.15% of Henry Schein worth $22,233,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of HSIC. SpiderRock Advisors LLC acquired a new position in shares of Henry Schein during the first quarter worth approximately $102,000. Lee Financial Co acquired a new position in shares of Henry Schein during the second quarter worth approximately $161,000. Westside Investment Management Inc. acquired a new position in shares of Henry Schein during the first quarter worth approximately $168,000. JNBA Financial Advisors acquired a new position in shares of Henry Schein during the first quarter worth approximately $170,000. Finally, Peddock Capital Advisors LLC increased its position in shares of Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares in the last quarter. 90.60% of the stock is owned by hedge funds and other institutional investors.

Henry Schein, Inc. (NASDAQ:HSIC) opened at 171.06 on Friday. The company has a market cap of $13.52 billion, a P/E ratio of 25.00 and a beta of 1.09. The firm’s 50-day moving average price is $178.25 and its 200-day moving average price is $175.78. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. Henry Schein shares are going to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly minted shares will be payable to shareholders after the closing bell on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter last year, the business posted $1.64 EPS. The business’s revenue was up 6.4% on a year-over-year basis. Analysts expect that Henry Schein, Inc. will post $7.27 EPS for the current year.

A number of research analysts recently commented on the company. Credit Suisse Group reissued a “hold” rating and issued a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. Barrington Research increased their price target on Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price target for the company in a report on Thursday, May 25th. Stifel Nicolaus increased their price target on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a report on Wednesday, May 10th. Finally, Piper Jaffray Companies assumed coverage on Henry Schein in a report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price target for the company. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.